FDA Panel Mulls Clinical Studies, Labeling For Over-The-Counter HIV Tests

Over-the-counter (OTC) HIV test kits would answer an unmet need, but clinical trials and product labeling must be carefully crafted to ensure that benefits outweigh the risks, according to FDA's Blood Products Advisory Committee